Charles River Laboratories (CRL) Tops Q4 EPS by 6c; Guides FY16 EPS Above Consensus Midpoint

Go back to Charles River Laboratories (CRL) Tops Q4 EPS by 6c; Guides FY16 EPS Above Consensus Midpoint

Charles River Laboratories (CRL) Gains Following Solid Results, Outlook

February 10, 2016 9:51 AM EST

Charles River Laboratories (NYSE: CRL) is seeing strong upside following better-than-expected earnings this morning. Shares are up 7.9%.

... More